Search

everythinglearnresearchcommunity

for

Search:↓

T cells and inflammation are crucial in atherosclerosis, with anti-inflammatory treatments showing promise.

In 2024, the FDA approved 27 innovative small-molecule drugs, with many offering significant treatment improvements.

Significant progress and collaborations in stem cell research and regenerative medicine were made, including advancements in hair growth, cancer therapies, and treatments for neurological disorders.

Hormones like androgens, estrogen, thyroid hormones, and stress hormones can contribute to hair loss, and treatments target these hormonal imbalances.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Some people experience lasting sexual, psychological, and sleep problems after using finasteride or SSRI antidepressants, possibly due to similar underlying causes.

PRP injections are safe but don't significantly improve Peyronie's Disease.

Polynucleotides might work well in esthetic medicine, but more research is needed.

Alopecia areata causes significant emotional and social challenges, especially with more hair loss.

Etrasimod is safe but not effective for severe alopecia areata, though it may help milder cases.

Baricitinib helps regrow hair in teens with severe alopecia areata.

Ivarmacitinib effectively regrows hair in severe alopecia areata.

Using mesenchymal stem cells or their exosomes is safe for COVID-19 patients and helps improve lung healing and oxygen levels.

Hydralazine and minoxidil are blood pressure medications that relax blood vessels, with potential side effects like rapid heartbeat and fluid retention, and are used for severe or pregnancy-related hypertension.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

A botanical extract blend improved skin and scalp health in women working outdoors.

New hair regrowth therapies show promise but need more research.

Bicalutamide may effectively treat female pattern hair loss with minimal side effects.

Proper scalp care can improve hair health and delay ageing signs.

Tadalafil and Finasteride may help treat aggressive melanoma.

Human fetal placental stromal cell injections speed up healing and improve skin and hair recovery after radiation damage.

Healthy scalp reduces hair loss by managing oxidative stress.

Frontal fibrosing alopecia significantly affects men, often causing hair loss in eyebrows, beard, and sideburns.

Serotonergic antidepressants can significantly increase the risk of erectile dysfunction and have a small risk of causing irreversible sexual dysfunction.

TheDES improve drug delivery through the skin but need more safety checks.

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.

Some drugs can cause skin reactions, which may improve when the drug is stopped, and rapid diagnosis and stopping the drug is crucial.

PFS and PSSD are similar conditions with persistent sexual dysfunction after stopping medication.

Two lotions used day and night may be a good alternative to minoxidil for hair loss, with better cosmetic effects and tolerance.